Breast Cancer
Latest News
Black women have higher state-level rates of TNBC
The state-level disparities highlight gaps in physicians’ understanding of how social factors contribute to disparities in TNBC risk.
News
Breast cancer less common in Black women, so why do more die?
This mortality gap likely reflects the fact that Black women face substantial barriers to obtaining timely, high-quality medical care, compared...
News
Breast cancer now leading cause of cancer death in Black women
"Black women are 41% more likely to die from breast cancer than White women despite a lower risk of being diagnosed with the disease."
Latest News
Radiologist fatigue affects breast imaging interpretation
The impact of time and experience on overall patient recall and false-positive rates has not been well-studied.
News
The evolving HER2+ metastatic breast cancer landscape: Novel agents and promising combination therapies
“The fact that we’re now talking about fourth- and fifth-line therapies for HER2-positive MBC represents a major advance in the management of...
Latest News
Liquid biopsy in metastatic breast cancer management: Where does it stand in clinical practice?
Liquid biopsies — blood analyses that allow oncologists to detect circulating tumor cells and circulating tumor DNA in the blood — are...
Latest News
Biomarker testing in metastatic breast cancer management: ‘Essential’
Defining a breast tumor can be tricky because these cancers often don’t fit neatly into predefined categories.
Latest News
Novel trastuzumab duocarmazine significantly improved survival in advanced HER2-positive breast cancer
Trastuzumab duocarmazine is a novel HER2-targeting antibody-drug conjugate which, according to the results of the TULIP trial recently presented...
News
Treatment shows 'important improvements' in triple-negative breast cancer
Survival of patients without an initial diagnosis of triple-negative breast cancer was better with the antibody-drug conjugate, compared with...
News
Better survival with extended letrozole in early-stage breast cancer
Guidelines for duration of endocrine therapy ‘should be updated.’